Works matching IS 00070920 AND DT 2010 AND VI 102 AND IP 6
Results: 24
MutSbeta exceeds MutSalpha in dinucleotide loop repair.
- Published in:
- 2010
- By:
- Publication type:
- journal article
The prognostic value of plasma fibrinogen levels in patients with endometrial cancer: a multi-centre trial.
- Published in:
- 2010
- By:
- Publication type:
- journal article
High frequency of beta-catenin heterozygous mutations in extra-abdominal fibromatosis: a potential molecular tool for disease management.
- Published in:
- 2010
- By:
- Publication type:
- journal article
8-Hydroxydeoxyguanosine: a new potential independent prognostic factor in breast cancer.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Preferences for colorectal cancer screening strategies: a discrete choice experiment.
- Published in:
- 2010
- By:
- Publication type:
- journal article
High expression of gabarapl1 is associated with a better outcome for patients with lymph node-positive breast cancer.
- Published in:
- 2010
- By:
- Publication type:
- journal article
'Desperate house genes': the dramatic example of hypoxia.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Identification of DBC1 as a transcriptional repressor for BRCA1.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Prevalence, risk factors and clinical implications of malnutrition in French Comprehensive Cancer Centres.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Combined effects of the bisphosphonate, zoledronic acid and the aromatase inhibitor letrozole on breast cancer cells in vitro: evidence of synergistic interaction.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma.
- Published in:
- 2010
- By:
- Publication type:
- journal article
KRAS status analysis and anti-EGFR therapies: is comprehensiveness a biologist's fancy or a clinical necessity?
- Published in:
- 2010
- By:
- Publication type:
- Letter
Reply: KRAS status analysis and anti-EGFR therapies: is comprehensiveness a biologist's fancy or a clinical necessity?
- Published in:
- 2010
- By:
- Publication type:
- Letter
Treatment of HER2-positive metastatic breast cancer with lapatinib and capecitabine in the lapatinib expanded access programme, including efficacy in brain metastases--the UK experience.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Influence of pharmacogenetics on response and toxicity in breast cancer patients treated with doxorubicin and cyclophosphamide.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Lysophosphatidic acid production and action: critical new players in breast cancer initiation and progression.
- Published in:
- 2010
- By:
- Publication type:
- journal article
High-resolution genomic profiling of human papillomavirus-associated vulval neoplasia.
- Published in:
- 2010
- By:
- Publication type:
- journal article
The G-protein-coupled formylpeptide receptor FPR confers a more invasive phenotype on human glioblastoma cells.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Are GPs under-investigating older patients presenting with symptoms of ovarian cancer? Observational study using General Practice Research Database.
- Published in:
- 2010
- By:
- Publication type:
- journal article
A comprehensive evaluation of the accuracy of cervical pre-cancer detection methods in a high-risk area in East Congo.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Oxaliplatin, irinotecan and capecitabine as first-line therapy in metastatic colorectal cancer (mCRC): a dose-finding study and pharmacogenomic analysis.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Letter to the Editor: SUN vs BEVþIFN in first-line mRCC therapy: no evidence for a statistically significant difference in progression-free survival.
- Published in:
- 2010
- By:
- Publication type:
- Correction Notice
Prospective study of predictors of vitamin D status and survival in patients with colorectal cancer.
- Published in:
- 2010
- By:
- Publication type:
- Correction Notice
MLH1 mediates PARP-dependent cell death in response to the methylating agent N-methyl-N-nitrosourea.
- Published in:
- 2010
- By:
- Publication type:
- Correction Notice